preloader icon



Apex Trader Funding (ATF) - News

Silver Spike Investment Corp. Reports First Quarter 2024 Financial Results and Announces Cash Dividend of $0.25 Per Share

NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Silver Spike Investment Corp. ("SSIC" or the "Company") (NASDAQ:SSIC), a specialty finance company that has elected to be regulated as a business development company, today announced its financial results for the first quarter ended March 31, 2024. Quarter Ended 3/31/24 Highlights Total investment income of $2.8 million Net investment income (loss) of $(0.1) million, or $(0.01) per share Investment portfolio of $54.8 million at fair value Net asset value ("NAV") per share decreased from $13.77 on December 31, 2023 to $13.60 on March 31, 2024 A cash dividend of $0.25 per share was declared. The dividend is payable on June 28, 2024 to stockholders of record on June 20, 2024. Scott Gordon, Chairman and Chief Executive Officer of the Company, commented "It was recently reported that the U.S. Drug Enforcement Administration ("DEA") is moving to reclassify cannabis to a Schedule III substance under the Controlled Substances Act, a potential historic shift in federal regulation of the cannabis industry. Although timing is uncertain, this shift would be a major step forward for the cannabis industry and should have a positive impact on cash flow for cannabis operators, as they would no longer be subject to Section 280E of the Internal Revenue Code, which prohibits the taking of deductions for businesses that engage in trafficking of controlled substances listed in Schedule I or Schedule II. Based on this news and an expected acceleration in refinancings, we anticipate an increase in cannabis capital markets activity in the second half of 2024. We believe that we will have the ability to deploy capital to new portfolio companies with favorable risk/reward characteristics for the foreseeable future, as the demand for capital will outweigh the supply." Loan Portfolio Acquisition AgreementOn February 20, 2024, the Company announced that it entered into a definitive agreement to purchase from Chicago Atlantic Loan Portfolio, LLC ("CALP") a portfolio of loans (the "CALP Loan Portfolio") in exchange for newly issued shares of the Company's common stock, subject to certain customary closing conditions (the "Loan Portfolio Acquisition"). On April 15, 2024, the Company filed a registration statement on Form N-14 in connection with the Loan Portfolio Acquisition with the Securities and Exchange Commission (the "SEC"). Results of OperationsFor the three months ended March 31, 2024, total investment income was $2.8 million. This compares to total expenses of $2.9 million, which includes $2.1 million of expenses related to the Loan Portfolio Acquisition, resulting in net investment income (loss) of $(0.1) million, or $(0.01) per share. The Company recorded a net unrealized gain of $0.6 million during the quarter ended March 31, 2024, primarily related to the fair valuation of our debt investments. The Company generated a net increase in net assets from operations of $0.5 million, or $0.08 per share. Net Asset ValueAs of March 31, 2024, NAV per share decreased to $13.60, compared to $13.77 as of December 31, 2023. The decrease in NAV per share was primarily driven by dividend payments. Total net assets as of March 31, 2024 were $84.5 million, compared to $85.6 million as of December 31, 2023. Portfolio and Investment Activity As of March 31, 2024, the Company's investment portfolio had an aggregate fair value of $54.8 million, comprising $46.6 million in secured loans in three portfolio companies and $8.2 million in secured notes in two portfolio companies. During the quarter ended March 31, 2024, the Company made no investments. As of March 31, 2024, there were no loans on non-accrual status. Liquidity and Capital ResourcesAs of March 31, 2024, the Company had $33.2 million in available liquidity, comprising $33.2 million in cash equivalents. DividendThe Company's Board of Directors declared a cash dividend of $0.25 per share. The following are the key dates for the dividend: Record Date June 20, 2024 Payment Date June 28, 2024 The Company has adopted a dividend reinvestment plan ("DRIP") that provides for reinvestment of dividends on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, when the Company declares a cash dividend, stockholders who have not "opted out" of the DRIP in accordance with the terms of the DRIP and the procedures of their broker or other financial intermediary will have their cash dividends automatically reinvested in additional shares of the Company's common stock. A stockholder whose shares are held by a broker or other financial intermediary should contact their broker or other financial intermediary as soon as possible in order to determine the time by which the stockholder must take action in order to receive dividends in cash. Conference Call The Company will host a conference call and webcast to discuss the Company's first quarter 2024 financial results at 8:00 a.m. Eastern Time on Friday, May 10, 2024. Participants may register for the call here. A live webcast of the call will also be available on the Company's website at ssic.silverspikecap.com. The presentation to be used in connection with the conference call and webcast will be available at ssic.silverspikecap.com. A replay of the call will be available at ssic.silverspikecap.com by end of day May 10, 2024. About Silver Spike Investment Corp.The Company is a specialty finance company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended, and has elected to be treated as a regulated investment company for U.S. federal income tax purposes. The Company's investment objective is to maximize risk-adjusted returns on equity for its shareholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies and other companies in the health and wellness sector. The Company is managed by Silver Spike Capital, LLC, an investment manager focused on the cannabis and alternative health and wellness industries. For more information, please visit ssic.silverspikecap.com. Forward-Looking StatementsSome of the statements in this communication constitute forward-looking statements because they relate to future events, future performance or financial condition of the Company or the Loan Portfolio Acquisition. The forward-looking statements may include statements as to: future operating results of the Company and distribution projections; business prospects of the Company and the prospects of its portfolio companies; and the impact of the investments that the Company expects to make. In addition, words such as "may," "might," "will," "intend," "should," "could," "can," "would," "expect," "believe," "estimate," "anticipate," "predict," "potential," "plan" or similar words indicate forward-looking statements, although not all forward-looking statements include these words. The forward-looking statements contained in this communication involve risks and uncertainties. Certain factors could cause actual results and conditions to differ materially from those projected, including the uncertainties associated with (i) the timing or likelihood of the Loan Portfolio Acquisition closing; (ii) the ability to realize the anticipated benefits of the Loan Portfolio Acquisition; (iii) the percentage of Company stockholders voting in favor of the proposals submitted for their approval; (iv) the possibility that competing offers or acquisition proposals will be made; (v) the possibility that any or all of the various conditions to the consummation of the Loan Portfolio Acquisition may not be satisfied or waived; (vi) risks related to diverting management's attention from ongoing business operations; (vii) the risk that stockholder litigation in connection with the Loan Portfolio Acquisition may result in significant costs of defense and liability; (viii) changes in the economy, financial markets and political environment, including the impacts of inflation and rising interest rates; (ix) risks associated with possible disruption in the operations of the Company or the economy generally due to terrorism, war or other geopolitical conflict (including the current conflict between Russia and Ukraine), natural disasters or global health pandemics, such as the COVID-19 pandemic; (x) future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities); (xi) changes in political, economic or industry conditions, the interest rate environment or conditions affecting the financial and capital markets that could result in changes to the value of the Company's assets; (xii) elevating levels of inflation, and its impact on the Company, on its portfolio companies and on the industries in which it invests; (xiii) the Company's plans, expectations, objectives and intentions, as a result of the Loan Portfolio Acquisition; (xiv) the future operating results and net investment income projections of the Company; (xv) the ability of Silver Spike Capital, LLC (the "Adviser") to locate suitable investments for the Company and to monitor and administer its investments; (xvi) the ability of the Adviser or its affiliates to attract and retain highly talented professionals; (xvii) the business prospects of the Company and the prospects of its portfolio companies; (xviii) the impact of the investments that the Company expects to make; (xix) the expected financings and investments and additional leverage that the Company may seek to incur in the future; (xx) conditions in the Company's operating areas, particularly with respect to business development companies or regulated investment companies; (xxi) the ability of CALP to obtain the necessary consents for, or otherwise identify and obtain additional loans for including in the CALP Loan Portfolio; (xxii) the regulatory requirements applicable to the transaction and any changes to the transaction necessary to comply with such requirements; (xxiii) the satisfaction or waiver of the conditions to the consummation of the transaction, and the possibility in that in connection that the closing will not occur or that it will be significantly delayed; (xxiv) the realization generally of the anticipated benefits of the Loan Portfolio Acquisition and the possibility that the Company will not realize those benefits, in part or at all; (xxv) the performance of the loans included in the CALP Loan Portfolio, and the possibility of defects or deficiencies in such loans notwithstanding the diligence performed by the Company and its advisors; (xxvi) the ability of the Company to realize cost savings and other management efficiencies in connection with the transaction as anticipated; (xxvii) the reaction of the trading markets to the transaction and the possibility that a more liquid market or more extensive analyst coverage will not develop for the Company as anticipated; (xxviii) the reaction of the financial markets to the transaction and the possibility that the Company will not be able to raise capital as anticipated; (xxix) the diversion of management's attention from the Company's ongoing business operations; (xxx) the risk of stockholder litigation in connection with the transaction; (xxxi) the strategic, business, economic, financial, political and governmental risks and other risk factors affecting the business of the Company and the companies in which it is invested as described in the Company's public filings with the SEC and (xxxii) other considerations that may be disclosed from time to time in the Company's publicly disseminated documents and filings. The Company has based the forward-looking statements included in this communication on information available to it on the date of this communication, and it assumes no obligation to update any such forward-looking statements. Although the Company undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that the Company may make directly to you or through reports that the Company in the future may file with the SEC, including the Proxy Statement/Prospectus, annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.  Additional Information and Where to Find ItThis communication relates to a proposed business combination involving the Company and CALP, along with the related proposals for which stockholder approval will be sought. In connection with the proposals, the Company has filed relevant materials with the SEC, including a registration statement on Form N-14, which includes a proxy statement and a prospectus of the Company (the "Proxy Statement/Prospectus"). This communication does not constitute ...